BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15555623)

  • 1. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells.
    Wu J; Harris NL; Inge TH
    J Surg Res; 2004 Dec; 122(2):231-9. PubMed ID: 15555623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.
    Lin X; Li Q; Wang YJ; Ju YW; Chi ZQ; Wang MW; Liu JG
    Biochem J; 2007 Sep; 406(2):215-21. PubMed ID: 17542780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WP744 is a novel anthracycline with enhanced activity against neuroblastoma.
    Inge TH; Harris NL; Wu J; Azizkhan RG; Priebe W
    J Surg Res; 2004 Oct; 121(2):187-96. PubMed ID: 15501458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
    Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
    Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
    Armstrong MB; Bian X; Liu Y; Subramanian C; Ratanaproeksa AB; Shao F; Yu VC; Kwok RP; Opipari AW; Castle VP
    Neoplasia; 2006 Nov; 8(11):967-77. PubMed ID: 17132229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism.
    Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Shin HY; Ahn HS; Ryu KH
    Pediatr Hematol Oncol; 2006; 23(3):231-43. PubMed ID: 16517539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells.
    Kim K; Ryu K; Ko Y; Park C
    Br J Haematol; 2005 Oct; 131(1):59-66. PubMed ID: 16173963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
    Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
    Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
    Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
    Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFkappaB activation and drug sensitivity in human neoplastic cells treated with anthracyclines.
    Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Fokt I; Piebe W
    Acta Pol Pharm; 2008; 65(2):267-71. PubMed ID: 18666436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells.
    Moon DO; Kim MO; Lee JD; Kim GY
    Cancer Lett; 2008 Jun; 264(2):192-200. PubMed ID: 18314260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.